Health Care • Medical/Dental Instruments
$20.44 ▲ +0.96
(+4.93%)
MKT CAP: $425.5M • VOL: 144.8K
52W L $11 52W H $25
SI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 |
|---|---|---|
| Revenue (Total Sales) | $47.3M | $31.6M |
| YoY Revenue Growth % | +49.6% | — |
| Gross Profit | $36.2M | $24.3M |
| Gross Margin % | 76.5% | 77.0% |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | -$26.3M | -$14.7M |
| Operating Margin % | -55.6% | -46.3% |
| Net Income (GAAP) | -$40.4M | -$15.6M |
| EBITDA (Normalized) | -$20.4M | -$11.4M |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | -$28.6M | -$14.1M |
| Capital Expenditures (CapEx) | $7.4M | $4.0M |
| Free Cash Flow (FCF) | -$36.0M | -$18.2M |
| FCF Margin % | -76.1% | -57.4% |
| Return on Invested Capital (ROIC %) | -16.1% | -45.0% |
| Cash & Short-Term Equivalents | $26.9M | $6.1M |
| Total Debt (Short + Long Term) | $14.9M | $14.7M |
| Total Stockholders' Equity | $140.8M | -$54.7M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SI.